These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29228900)

  • 41. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developmental perfluorooctane sulfonate exposure results in tau hyperphosphorylation and β-amyloid aggregation in adults rats: Incidence for link to Alzheimer's disease.
    Zhang Q; Zhao H; Liu W; Zhang Z; Qin H; Luo F; Leng S
    Toxicology; 2016 Mar; 347-349():40-6. PubMed ID: 27018931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
    Wilson MA; Biscardi R; Smith MD; Wilson SP
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1073-82. PubMed ID: 8819488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons.
    Bertrand J; Plouffe V; Sénéchal P; Leclerc N
    Neuroscience; 2010 Jun; 168(2):323-34. PubMed ID: 20394726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease.
    Gratuze M; El Khoury NB; Turgeon A; Julien C; Marcouiller F; Morin F; Whittington RA; Marette A; Calon F; Planel E
    Neurobiol Dis; 2017 Feb; 98():1-8. PubMed ID: 27793638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of Alzheimer-like tau hyperphosphorylation and fMRI bold intensity.
    Xiao-Chuan W; Zheng-Hui H; Zheng-Yu F; Yue F; Yun-Huang Y; Qun W; Xiao-Wei T; Yi-Gen W; Jian-Zhi W
    Curr Alzheimer Res; 2004 May; 1(2):143-8. PubMed ID: 15975079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxia-induced tau phosphorylation and memory deficit in rats.
    Zhang CE; Yang X; Li L; Sui X; Tian Q; Wei W; Wang J; Liu G
    Neurodegener Dis; 2014; 14(3):107-16. PubMed ID: 24993525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
    Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
    J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noise stress changes mRNA expressions of corticotropin-releasing hormone, its receptors in amygdala, and anxiety-related behaviors.
    Eraslan E; Akyazi I; Erg L-Ekiz E; Matur E
    Noise Health; 2015; 17(76):141-7. PubMed ID: 25913553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melatonin attenuates isoproterenol-induced protein kinase A overactivation and tau hyperphosphorylation in rat brain.
    Wang DL; Ling ZQ; Cao FY; Zhu LQ; Wang JZ
    J Pineal Res; 2004 Aug; 37(1):11-6. PubMed ID: 15230863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic changes of phosphorylated tau in mouse hippocampus after cold water stress.
    Feng Q; Cheng B; Yang R; Sun FY; Zhu CQ
    Neurosci Lett; 2005 Nov; 388(1):13-6. PubMed ID: 16005567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tau Mislocation in Glucocorticoid-Triggered Hippocampal Pathology.
    Pinheiro S; Silva J; Mota C; Vaz-Silva J; Veloso A; Pinto V; Sousa N; Cerqueira J; Sotiropoulos I
    Mol Neurobiol; 2016 Sep; 53(7):4745-53. PubMed ID: 26328538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
    Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
    Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats.
    Molobekova CA; Kondaurova EM; Ilchibaeva TV; Rodnyy AY; Stefanova NA; Kolosova NG; Naumenko VS
    Curr Alzheimer Res; 2023; 20(7):496-505. PubMed ID: 37641989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β.
    Wang XL; Zeng J; Yang Y; Xiong Y; Zhang ZH; Qiu M; Yan X; Sun XY; Tuo QZ; Liu R; Wang JZ
    J Alzheimers Dis; 2015; 43(1):153-65. PubMed ID: 25079798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of corticotropin releasing factor-containing neurons in the rat central amygdala and bed nucleus of the stria terminalis following exposure to two different anxiogenic stressors.
    Butler RK; Oliver EM; Sharko AC; Parilla-Carrero J; Kaigler KF; Fadel JR; Wilson MA
    Behav Brain Res; 2016 May; 304():92-101. PubMed ID: 26821289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.